Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Molecular Biomarkers market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Molecular Biomarkersmarket, defines the market attractiveness level of Cancer Molecular Biomarkers market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Molecular Biomarkers industry, describes the types of Cancer Molecular Biomarkers market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Molecular Biomarkers market and the development prospects and opportunities of Cancer Molecular Biomarkers industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Molecular Biomarkers market in Chapter 13.
By Player:
Becton
Astellas Pharma US
Correlogic Systems
Diadexus
AgendiaBv
Biomoda
BioMerieux
Beckman Coulter
Dickinson
Abbott Laboratories
Clarient
Affymetrix
Aureon Laboratories
By Type:
Genetic Methods
Protein Methods
Imaging
By End-User:
Pharmaceutical Companies
Medical Laboratory
Hospital
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Molecular Biomarkers Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Molecular Biomarkers Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Molecular Biomarkers Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Molecular Biomarkers Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Molecular Biomarkers Market Analysis and Outlook to 2022
-
7.1 Global Cancer Molecular Biomarkers Consumption (2017-2022)
-
7.2 United States Cancer Molecular Biomarkers Consumption (2017-2022)
-
7.3 Europe Cancer Molecular Biomarkers Consumption (2017-2022)
-
7.4 China Cancer Molecular Biomarkers Consumption (2017-2022)
-
7.5 Japan Cancer Molecular Biomarkers Consumption (2017-2022)
-
7.6 India Cancer Molecular Biomarkers Consumption (2017-2022)
-
7.7 South Korea Cancer Molecular Biomarkers Consumption (2017-2022)
8 Region and Country-wise Cancer Molecular Biomarkers Market Analysis and Outlook to 2028
-
8.1 Global Cancer Molecular Biomarkers Consumption Forecast (2022-2028)
-
8.2 United States Cancer Molecular Biomarkers Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Molecular Biomarkers Consumption Forecast (2022-2028)
-
8.4 China Cancer Molecular Biomarkers Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Molecular Biomarkers Consumption Forecast (2022-2028)
-
8.6 India Cancer Molecular Biomarkers Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Molecular Biomarkers Consumption Forecast (2022-2028)
9 Global Cancer Molecular Biomarkers Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Molecular Biomarkers Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Genetic Methods Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Protein Methods Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Imaging Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Molecular Biomarkers Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Laboratory Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hospital Consumption and Growth Rate (2017-2022)
10 Global Cancer Molecular Biomarkers Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Molecular Biomarkers Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Genetic Methods Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Protein Methods Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Imaging Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Molecular Biomarkers Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Molecular Biomarkers Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Molecular Biomarkers Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Molecular Biomarkers Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Molecular Biomarkers Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Molecular Biomarkers Market Competitive Analysis
-
14.1 Becton
-
14.1.1 Becton Company Details
-
14.1.2 Becton Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Becton Cancer Molecular Biomarkers Product and Service
-
14.2 Astellas Pharma US
-
14.2.1 Astellas Pharma US Company Details
-
14.2.2 Astellas Pharma US Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Pharma US Cancer Molecular Biomarkers Product and Service
-
14.3 Correlogic Systems
-
14.3.1 Correlogic Systems Company Details
-
14.3.2 Correlogic Systems Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Correlogic Systems Cancer Molecular Biomarkers Product and Service
-
14.4 Diadexus
-
14.4.1 Diadexus Company Details
-
14.4.2 Diadexus Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Diadexus Cancer Molecular Biomarkers Product and Service
-
14.5 AgendiaBv
-
14.5.1 AgendiaBv Company Details
-
14.5.2 AgendiaBv Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AgendiaBv Cancer Molecular Biomarkers Product and Service
-
14.6 Biomoda
-
14.6.1 Biomoda Company Details
-
14.6.2 Biomoda Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biomoda Cancer Molecular Biomarkers Product and Service
-
14.7 BioMerieux
-
14.7.1 BioMerieux Company Details
-
14.7.2 BioMerieux Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 BioMerieux Cancer Molecular Biomarkers Product and Service
-
14.8 Beckman Coulter
-
14.8.1 Beckman Coulter Company Details
-
14.8.2 Beckman Coulter Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Beckman Coulter Cancer Molecular Biomarkers Product and Service
-
14.9 Dickinson
-
14.9.1 Dickinson Company Details
-
14.9.2 Dickinson Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Dickinson Cancer Molecular Biomarkers Product and Service
-
14.10 Abbott Laboratories
-
14.10.1 Abbott Laboratories Company Details
-
14.10.2 Abbott Laboratories Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Laboratories Cancer Molecular Biomarkers Product and Service
-
14.11 Clarient
-
14.11.1 Clarient Company Details
-
14.11.2 Clarient Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Clarient Cancer Molecular Biomarkers Product and Service
-
14.12 Affymetrix
-
14.12.1 Affymetrix Company Details
-
14.12.2 Affymetrix Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Affymetrix Cancer Molecular Biomarkers Product and Service
-
14.13 Aureon Laboratories
-
14.13.1 Aureon Laboratories Company Details
-
14.13.2 Aureon Laboratories Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Aureon Laboratories Cancer Molecular Biomarkers Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Molecular Biomarkers
-
Figure Cancer Molecular Biomarkers Picture
-
Table Global Cancer Molecular Biomarkers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Molecular Biomarkers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Molecular Biomarkers Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Molecular Biomarkers Consumption by Country (2017-2022)
-
Figure United States Cancer Molecular Biomarkers Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Molecular Biomarkers Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Molecular Biomarkers Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Molecular Biomarkers Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Molecular Biomarkers Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Molecular Biomarkers Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Molecular Biomarkers Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Molecular Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Molecular Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Molecular Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Molecular Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Molecular Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Molecular Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Methods Consumption and Growth Rate (2017-2022)
-
Figure Global Protein Methods Consumption and Growth Rate (2017-2022)
-
Figure Global Imaging Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Laboratory Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Methods Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protein Methods Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Imaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Molecular Biomarkers Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Molecular Biomarkers Export by Region (Top 5 Countries) (2017-2028)
-
Table Becton (Foundation Year, Company Profile and etc.)
-
Table Becton Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Cancer Molecular Biomarkers Product and Service
-
Table Astellas Pharma US (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma US Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma US Cancer Molecular Biomarkers Product and Service
-
Table Correlogic Systems (Foundation Year, Company Profile and etc.)
-
Table Correlogic Systems Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Correlogic Systems Cancer Molecular Biomarkers Product and Service
-
Table Diadexus (Foundation Year, Company Profile and etc.)
-
Table Diadexus Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Diadexus Cancer Molecular Biomarkers Product and Service
-
Table AgendiaBv (Foundation Year, Company Profile and etc.)
-
Table AgendiaBv Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table AgendiaBv Cancer Molecular Biomarkers Product and Service
-
Table Biomoda (Foundation Year, Company Profile and etc.)
-
Table Biomoda Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomoda Cancer Molecular Biomarkers Product and Service
-
Table BioMerieux (Foundation Year, Company Profile and etc.)
-
Table BioMerieux Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMerieux Cancer Molecular Biomarkers Product and Service
-
Table Beckman Coulter (Foundation Year, Company Profile and etc.)
-
Table Beckman Coulter Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beckman Coulter Cancer Molecular Biomarkers Product and Service
-
Table Dickinson (Foundation Year, Company Profile and etc.)
-
Table Dickinson Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dickinson Cancer Molecular Biomarkers Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Cancer Molecular Biomarkers Product and Service
-
Table Clarient (Foundation Year, Company Profile and etc.)
-
Table Clarient Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clarient Cancer Molecular Biomarkers Product and Service
-
Table Affymetrix (Foundation Year, Company Profile and etc.)
-
Table Affymetrix Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affymetrix Cancer Molecular Biomarkers Product and Service
-
Table Aureon Laboratories (Foundation Year, Company Profile and etc.)
-
Table Aureon Laboratories Cancer Molecular Biomarkers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aureon Laboratories Cancer Molecular Biomarkers Product and Service
-
